Cold News and Research

RSS

Tel Aviv scientist uncovers a new way of detecting multiple sclerosis

Multiple sclerosis (MS) is an equal opportunity destroyer. It attacks the central nervous system and eventually renders most patients disabled. Among its high-profile victims are celebrated cellist Jacqueline du Pre, whose career was ended by MS, and Joan Didion, one of America's greatest writers - but they are far from alone.

30 Apr 2010

Ago2 protein helps generate microRNAs: CSHL researchers

MicroRNAs are small bits of RNA within cells that wield enormous power. They influence virtually every biological process by controlling the "expression" of genes. Helping them in exerting this control is a unique class of proteins called Argonautes.

29 Apr 2010

Scientists discover human DNA that act as a traitor to body's defences

Cancer Research UK-funded scientists have discovered that stretches of human DNA act as a traitor to the body's defences by helping viruses infect people and trigger cancer-causing diseases, according to a study published in Nature Cell Biology today.

28 Apr 2010

Top ten tips for managing healthcare

America's healthcare system is about to undergo the most fundamental transformation in our nation's history. An already over-stressed system must absorb 32 million new patients at the same time that the country's huge baby boomer population is likely to need ever more medical attention as they age. And many of our most experienced and talented physicians will soon reach retirement age, leaving fewer experienced doctors to treat more patients.

28 Apr 2010

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.

28 Apr 2010

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.

28 Apr 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

Life Technologies Corporation today announced results for its first quarter ending March 31, 2010. Non-GAAP revenue for the first quarter was $887 million, an increase of 13 percent over the $785 million reported for the first quarter of 2009. Excluding the impact of currency and completed acquisitions and divestitures, organic revenue for the quarter grew 10 percent over the same period in the previous year.

28 Apr 2010

Medication-free home ventilation system designed to remove allergens

According to a recent report by USA Today, due to 2010's unusually cold winter temperatures, allergy sufferers are now poised to experience the worst pollen season in years, with pollen counts skyrocketing and sufferers hiding indoors to avoid exposure. Yet as allergens creep indoors, sufferers continue to cough, sneeze and seek relief. With the introduction of EZ Breathe, a new innovative home ventilation system designed to remove allergens and reduce indoor concentrations of pollen, allergy sufferers now have a medication-free solution.

27 Apr 2010

Dozens of states pass, debate greater restrictions on abortion

Dozens of states are passing or debating new restrictions on abortion, a trend fueled in part by passage of the nation's new health care law. Both sides of the hot-button issue are seeing new approaches to reduce abortions. … So far, 2010 has been 'very successful,' said Mary Spaulding Balch of the National Right to Life Committee.

26 Apr 2010

First Edition: April 26, 2010

Today's headlines reflect state-level health policy developments as well as forward-looking stories related to the cost of federal health reforms.

26 Apr 2010

Temperature-sensing ability in proteins remain a mystery

Scientists at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have shed new light on the molecular mechanism that enables us to sense temperature, such as the heat from a sizzling stove. In addition to contributing to our knowledge of basic biology, the findings could one day lead to new therapies for conditions such as acute or chronic inflammatory pain.

24 Apr 2010

U.S., other donors commit $880M for new World Bank-hosted Global Food Security fund

The U.S. Treasury Thursday announced $880 million in contributions from the U.S., Canada, Spain, South Korea and the Bill & Melinda Gates Foundation for the new World Bank-hosted Global Agriculture and Food Security Program, Reuters reports (Lawder, 4/22).

24 Apr 2010

UIC College of Dentistry awarded $10M federal grant to upgrade research facilities

The University of Illinois at Chicago College of Dentistry has received a $10 million federal grant to transform its research facilities into a state-of-the-art clinical and translational research center.

23 Apr 2010

Deadly fungus on the move

Researchers revealed this Thursday that a deadly fungus that is usually found only in the tropics is making its way to the Pacific Coast of British Columbia and south into Washington, Oregon and Idaho.

23 Apr 2010

BUSM professor receives Individual Biomedical Research Award

Richard Goldstein, PhD, a professor of pediatrics, division of pediatric infectious diseases, at Boston University School of Medicine, has been awarded an Individual Biomedical Research Award by The Hartwell Foundation and will receive $300,000 over three years as a Hartwell Investigator for his project titled, "A Vaccine Against Streptococcus Pneumoniae Based on Bacterial Surface Proteins Phylogenically Certified as Highly Conserved."

23 Apr 2010

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics.

22 Apr 2010

KSERA research project focuses on COPD patients

To enable elderly people to live at home as long as possible, a group of European researchers, coordinated from Eindhoven University of Technology, will link robots and 'smart homes'. The robot, a 'sensible family friend', will ensure that home is a nice place to stay. And that patients do the right things.

22 Apr 2010

Ozone and primary pollutants from traffic increase asthma-related emergency department visits in children

Both ozone and primary pollutants from traffic substantially increase asthma-related emergency department visits in children, especially during the warm season, according to researchers from the Department of Environmental Health at the Rollins School of Public Health at Emory University in Atlanta.

22 Apr 2010

Sonic Innovations wins Best in Show award at AudiologyNOW! conference

Sonic Innovations, Inc. received a Best in Show award based on attendees' votes at the AudiologyNOW! conference for its tradeshow booth. The conference was held April 14 through 17 in San Diego, California and was attended by nearly 7,000 hearing care professionals.

21 Apr 2010

InfoLogix launches HealthTrax mobility solution for University Health System

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today it has successfully launched a customized HealthTrax mobility solution for University Health System's 604-bed acute care hospital and 20 ambulatory clinics in San Antonio, Texas.

21 Apr 2010